[1]
Stoynova, M. et al. 2023. Current therapeutic options in active moderate-to-severe thyroid-associated ophthalmopathy. Acta Medica Bulgarica. 50, 4 (Dec. 2023), 59–68. DOI:https://doi.org/10.2478/AMB-2023-0045.